XEVUDY conc perf 500 mg/8ml flac 8 ml
7680684710018
CH-68471
J06BD05
08.03.0.
1 / 3
google
Details
- Product number
- 6847101
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- sotrovimabum 500 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, methioninum, aqua ad iniectabile q.s. ad solutionem pro 8 ml.
Articles (1)
Xevudy, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
sotrovimabum
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
methioninum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 68471
- Drug name
- Xevudy, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- J06BD05
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- A
- First authorization
- 14/01/2022
- Authorization expiration date
- 13/11/2025
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- XEVUDY conc perf 500 mg/8ml flac 8 ml
- Description (DE)
- XEVUDY Inf Konz 500 mg/8ml Durchstf 8 ml
- Market launch
- 14/01/2022
- Market withdrawal
- 29/08/2024
- Narcotic (BTM)
- No